Donnelly Joseph, Gabriels James, Galmer Andrew, Willner Jonathan, Beldner Stuart, Epstein Laurence M, Patel Apoor
Department of Cardiology, North Shore University Hospital, 300 Community Dr, Manhasset, NY, 11030, USA.
Curr Treat Options Cardiovasc Med. 2018 Jul 11;20(8):64. doi: 10.1007/s11936-018-0664-5.
A variety of complex vascular pathologies arise following the implantation of electronic cardiac devices. Pacemaker and defibrillator lead insertion may cause proximal venous obstruction, resulting in symptomatic venous congestion and the compromise of potential future access sites for cardiac rhythm lead management.
Various innovative techniques to recanalize the vein and establish alternate venous access have been pioneered over the past few years. A collaborative team of electrophysiologists and vascular specialists strategically integrate the patient's vascular disease into the planning of electrophysiology procedures. When vascular complications occur after device implantation, the same team effectively manages both the resulting vascular sequelae and related cardiac rhythm device challenges. This review will outline the various vascular challenges related to device therapy and offer an effective strategy for their management.
植入电子心脏设备后会出现多种复杂的血管病变。起搏器和除颤器导线插入可能导致近端静脉阻塞,从而引起有症状的静脉充血,并使未来用于心律导线管理的潜在通路部位受损。
在过去几年中,已经开创了各种用于重新疏通静脉和建立替代静脉通路的创新技术。电生理学家和血管专家组成的协作团队在电生理程序规划中战略性地整合患者的血管疾病。当设备植入后出现血管并发症时,同一团队有效地管理由此产生的血管后遗症以及相关的心律设备问题。本综述将概述与设备治疗相关的各种血管挑战,并提供有效的管理策略。